Knockdown of arsenic resistance protein 2 inhibits human glioblastoma cell proliferation through the MAPK/ERK pathway

It is generally known that glioblastoma is the most common primary malignant brain tumor and that it is highly aggressive and deadly. Although surgical and pharmacological therapies have made long-term progress, glioblastoma remains extremely lethal and has an uncommonly low survival rate. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Xiao-Xue, Pang, Yi, Chen, Kuijun, Zhang, Dunke, Wang, Feng, Zhu, Shunqin, Mao, Jingxin, Hu, Xiaosong, Zhang, Guanghui, Cui, Hongjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196630/
https://www.ncbi.nlm.nih.gov/pubmed/30542699
http://dx.doi.org/10.3892/or.2018.6777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196630/
https://www.ncbi.nlm.nih.gov/pubmed/30542699
http://dx.doi.org/10.3892/or.2018.6777

Ejemplares similares